Presented By Deborah Schrag at 2016 ASCO Annual Meeting The Association Between Primary Tumor Location and Survival in Colorectal Cancer Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Study Motivation Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Study Objective Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Study Data Sources: <br />18 Tumor Registries in NCI‘s SEER Program since 2000<br />Linkage to Medicare Enrollment and Claims Data Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Study Methods Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Categorization of Colorectal Primary Sites<br /> Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Tumor Location and Age, Stage At Diagnosis Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Stage IV Colorectal Cancer <br />by Primary Tumor Location and Year of Diagnosis<br /> Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Overall Survival for Stage IV CRC from SEER <br />by Tumor Location, 2000-2012 Diagnoses Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Overall Survival for Stage IV CRC in SEER<br />by Primary Tumor Location, 2000-2012 Diagnoses Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Overall Survival for Stage IV CRC <br />by Primary Tumor Location and Year of Diagnosis<br /> Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting <br />Stage IV CRC Median Survival in Months<br />by Primary Tumor Location and Year of Diagnosis Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Overall Survival in Stage III CRC <br />by Primary Tumor Location, 2000-2012 Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Overall Survival for Stage III CRC <br />by Primary Tumor Location and Year of Diagnosis Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Stage III CRC Median Survival in Months<br />by Primary Tumor Location and Year of Diagnosis Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Overall Survival in Stage II CRC <br />by Primary Tumor Location, 2000-2012 Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Is the Association Between Sidedness and Prognosis All Lead Time? Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Stage III CRC By Primary Tumor Location and Substage Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Overall Survival for Stage III CRC <br />by tumor location and AJCC sub-stage Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting <br />Stage IV subgroup diagnosed 2004-2011 enrolled in Medicare and treated with Cetuximab or panitumumab ascertained from Medicare claimss<br /> Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Stage IV: Survival from first dose of Cetuximab/P-mab Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Discussion: Relating Phenotype to Genotype<br />Consensus Molecular Subtypes in Colorectal Cancer Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Discussion: Relating Phenotype to Genotype<br />Consensus Molecular Subtypes Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Study Conclusions Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting THANK YOU! Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Presented By Deborah Schrag at 2016 ASCO Annual Meeting Stage III Colorectal Cancer <br />by Primary Tumor Location and Year of Diagnosis Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Stage IV CRC: <br />Adjusted Hazard Ratios for Overall Survival Presented By Deborah Schrag at 2016 ASCO Annual Meeting